Accelerate organic growth in China’s competitive pharmaceutical market with tailored, enterprise-level link building services. From global digital PR placements to high-impact niche backlinks, The Trust Agency delivers measurable SEO results with full-spectrum precision.
Everything you need for enterprise-grade link building
Tailored link building campaigns aligned to China pharmaceutical KPIs and local search dynamics ensure strategies are built for market realities. This planning prioritizes compliant, industry‑appropriate placements to drive sustainable visibility on Baidu and other Chinese channels.
Secures guest posts and digital PR placements on top Chinese healthcare portals, medical news sites, and mainstream outlets to build trust with clinicians and patients. These authoritative mentions strengthen citation signals and drive relevant referral traffic from trusted Chinese sources.
Targets links from Chinese medical universities, hospital sites, and professional association domains to create powerful trust signals critical for pharmaceutical brands. Links from these authoritative domains materially boost credibility and domain authority within regulated healthcare searches.
Produces Mandarin‑optimized content and places links on China‑specific platforms like WeChat articles, Zhihu, Sohu and Sina to reach practitioners and patients in‑market. Localized distribution increases cultural relevance and improves rankings on Chinese search engines.
Implements white‑hat, compliance‑first link strategies that respect NMPA rules and China’s healthcare advertising restrictions to minimize legal and reputational exposure. Manual vetting and policy-aware outreach reduce chances of penalties while preserving long‑term SEO value.
Leverages digital PR campaigns and outreach to Chinese medical KOLs and industry influencers to secure expert mentions, interviews, and quoted backlinks on trusted channels. Such endorsements generate high‑quality backlinks and strengthen trust among local audiences and professionals.
Offers flexible monthly, contract‑free, and enterprise plans that let pharmaceutical clients scale link acquisition as launches, approvals, or regional priorities change in China. This adaptability supports rapid market tests, controlled rollouts, or steady compliance‑focused growth.
Delivers clear reporting with China‑specific KPIs (Baidu ranking movement, referral traffic from Chinese domains, and local domain authority signals) plus manual quality audits on placements. Full transparency enables pharma stakeholders to demonstrate ROI and maintain records for regulatory review.
Our proven process for delivering results
We audit your China pharmaceutical brand, target markets (mainland China vs. global), competitor backlink profiles, and regulatory constraints (NMPA, medical advertising rules) to shape a safe link plan. This establishes allowed claims, target keywords, and the best link types for pharmaceutical SEO in China.
We design a bespoke link plan blending white‑hat editorial PR, high‑authority medical/journal placements, localized Chinese portals, and selective technical links to meet your KPIs. The plan specifies cadence, anchor diversification, language/localization, and any advanced tactics (e.g., controlled PBNs) where risk-tolerance and objectives permit.
Our team produces medically accurate, compliance‑checked content-whitepapers, guest articles, expert comments, and localized Chinese content-positioned for authoritative placements. All content is optimized for target keywords and formatted to meet editorial standards of top Chinese medical sites and journals.
We perform hands‑on outreach to vetted Chinese healthcare portals, university pages, medical journals, and industry editors to secure one‑way, high‑quality placements. Each link is validated for relevance, placement context, anchor text, and compliance before acceptance.
You receive transparent monthly reports showing acquired links, authority metrics, organic movement, and any regulatory checks, plus recommended next steps. We iterate strategy based on results and scale the link pipeline while continuously monitoring for compliance and profile diversification.
See how leading companies leverage our advanced link building services
Enterprise-grade link building that delivers measurable results
Access specialists focused on pharmaceutical domains, edu links, HARO responses, and placements in Chinese medical portals to ensure relevance and credibility. These experts understand regulatory language, KOL outreach, and journal standards specific to China’s pharma ecosystem.
Systematically build domain authority with high-quality placements on reputable medical sites, industry journals, and government-adjacent portals to improve trust with healthcare professionals and regulators. Strong authority signals help pharma brands rank for clinical and product-related queries both in China and internationally.
Manual outreach combined with AI-driven prospecting and editorial vetting ensures each placement meets medical accuracy and regulatory expectations. This reduces the risk of low-quality or non-compliant links that could harm reputation or trigger platform penalties.
Campaigns are tailored to your KPIs-whether that’s HCP engagement, product awareness, or regulatory information dissemination-and incorporate content and outreach approaches aligned with Chinese regulatory requirements. The strategy maps placements to measurable outcomes so every link supports a clear business objective.
Execute multilingual, multi-location campaigns that target mainland China, regional Chinese-language markets, and international medical journals to support cross-border clinical and market access goals. This enables synchronized link signals across markets that matter for pharma reputation and research discoverability.
Balance natural organic links, authoritative editorial placements, and selective strategic opportunities to create a resilient link profile that avoids over-reliance on risky sources. The approach minimizes algorithmic and compliance risks while maintaining steady authority growth.
Provide full visibility into placements, content, referral traffic, and keyword performance with reports designed for medical marketing and compliance reviews. Transparent logs and dashboards make it simple to demonstrate link provenance during audits or regulatory checks.
Eliminate thousands of hours spent vetting sites, negotiating placements, and managing outreach so internal teams can focus on clinical development and regulatory tasks. Faster onboarding and execution shorten time-to-first-placement for timely product or research launches.
Act as your complete external link building team-handling prospecting, outreach, content creation, and placement management-so you don’t need to hire or train in-house specialists. This model provides predictable capacity and expertise aligned with pharmaceutical timelines and standards.
Outpace competitors by consistently acquiring high-quality, relevant links that improve rankings for clinical, product, and regulatory search terms important to the China pharma market. A focused acquisition cadence and niche placements strengthen discoverability among HCPs, researchers, and decision-makers.
Everything you need to know about our link building services
We begin with a discovery call to understand your therapeutic areas, regulatory constraints, target markets (mainland China vs. international), and KPIs. From there we create a custom strategy, propose a campaign roadmap, and start site prospecting and compliance checks before any outreach begins.
We secure a full spectrum of placements including Chinese-language industry portals, niche medical publisher guest posts, digital PR on authoritative outlets, bilingual editorial mentions, inbound links from international high-authority sites, and targeted resource listings. We also offer specialized placements like edu-style citations, HARO-style expert contributions, and contextual links on regulatory-trusted domains.
Every target site is manually vetted for editorial quality, domain authority, audience relevance, and regulatory suitability; we review content to avoid promotional medical claims and can route content through your legal or medical review. Our outreach prioritizes trustworthy, policy-compliant publications and documents all approvals and editorial policies for auditability.
Yes - each campaign is fully bespoke: we tailor outreach lists, content messaging, language (Simplified Chinese, Traditional Chinese, English), and risk profile based on your therapeutic focus and local regulatory requirements. You control the level of aggressiveness and can choose mixes of white-hat editorial, niche guest posts, or more controlled assets like Web 2.0 and PBNs where appropriate.
Pricing is campaign-specific and depends on target site authority, volume, content complexity, and whether you need Chinese-local placements versus international coverage. We offer scalable monthly plans, contract-free options, and white-label pricing for agencies - after an initial brief we provide a transparent proposal with tiered packages and expected deliverables.
Monthly deliverables typically include a list of secured placements with URLs, publication screenshots, content copies, anchor text and link type details, and a summary of outreach activity (pitches sent, responses, and negotiations). For regulated campaigns we also provide compliance logs showing review approvals and any editorial revisions.
We provide detailed, regular reporting with placement verification, backlink metrics, traffic and referral snapshots, and progress against KPIs; reports can be localized to Baidu analytics or Google Search Console data as required. All outreach records, editorial guidelines, and asset versions are stored in a client portal for full auditability.
Yes - we provide full white-label services including client-facing deliverables, branded reporting, and API or dashboard access so agencies can resell our link building under their brand. Reseller agreements include flexible SLA tiers, confidential account handling, and optional co-branded PR campaigns for market expansion.
Initial placements can begin within 4–8 weeks depending on outreach complexity and editorial cycles, with ongoing acquisition thereafter; measurable organic impact typically emerges over 3–6 months as links index and authority accumulates. Timelines vary by regulatory review needs, target publication speed, and competitive landscape.
We do not guarantee specific rankings, as search performance depends on many external factors beyond link acquisition; however, we mitigate risk through strict editorial vetting, compliance reviews, diversified link profiles, and white-hat tactics to maximize long-term safety. For higher-risk approaches we document risk trade-offs and provide options so you can choose the appropriate balance of growth and safety.
Get started with The Trust Agency and unlock enterprise-grade link building that delivers measurable SEO results.
Instant access to 100,000+ backlinks, innovative SEO tools, and expert support.
Already have an account? Sign in